Literature DB >> 1112976

Use of radioimmunoassays to determine the concentration of streptococcal group-specific antibodies in rabbit antisera.

D Bernstein, D G Klapper, R M Krause.   

Abstract

A radioimmunoassay was developed for the quantitation of antibodies to the Group A, A-variant, and C carbohydrates in rabbit streptococcal antisera. The assay employs radiolabeled purified Group carbohydrate which has been tyrosylated to allow for incorporation of 125-I. This assay has an advantage over the intitative precipitin test because it measures non-precipitating antibody in addition to precipitating antibody. Furthermore, 7S anti-IgG in rabbit antisera give a falsely elevated value for the antibody concentration in the quantitative precipitin test. This did not occur with the radioimmunoassay. The assay described is reproducible, sensitive, and uses little antisera.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1112976

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Specific immunoglobulin A antibodies to a peptide subunit sequence of bacterial cell wall peptidoglycan.

Authors:  N Franken; P H Seidl; T Kuchenbauer; H J Kolb; K H Schleifer; L Weiss; K D Tympner
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

2.  T lymphocyte-mediated cytolysis. III. Delineation of mechanisms whereby mitogenic and non-mitogenic lectins mediate lymphocyte-target interaction.

Authors:  G Berke; D Rosen; M Moscovitch
Journal:  Immunology       Date:  1983-08       Impact factor: 7.397

3.  Modulation of the susceptibility of inbred and outbred rats to arthritis induced by cell walls of group A streptococci.

Authors:  S K Anderle; J J Greenblatt; W J Cromartie; R Clark; J H Schwab
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

4.  Inheritance patterns of idiotype expression: maternal-fetal immune regulatory networks.

Authors:  J C Olson; G A Leslie
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.